The cagrilintide semaglutide mix in the CagriSema program has shown unprecedented effect in clinical trials, with the Phase 3 REDEFINE program showing average weight loss of 25% of total body weight over 68 weeks
(2006) noted the antimetastatic effect of epithalon, using the peptide to slow down the development of metastases from spontaneous tumors in female mice that were otherwise prone to reproductive organ tumors [8]
Always check local laws and consult with a healthcare professional before using the peptide
Note, the cytoprotection concept made by Robert (prevention of stomach epithelial cell necrosis) [41,42,43,44] and Szabo (endothelium protection) [45,46,47,48,49,50] links the original protection of stomach epithelial cells to the protection of other organs (organoprotection) [42,47] (i.e., for eye pharmacotherapy, stomach epithelium behaves like eye epithelium [15]), and stomach-cytoprotective agents to agents with pleiotropic beneficial effect [42,47]